Reducing Lung CongestIon Symptoms in Advanced Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 605 participants.
Also called NCT03499236
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 605 participants
- Sponsor
- V-Wave Ltd
- Registry
-
NCT03499236
-
- Other papers using this trial's data
- Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial
- Mechanistic Basis for Differential Effects of Interatrial Shunt Treatment in HFrEF vs HFpEF: The RELIEVE-HF Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States, Australia, Belgium, Canada, Germany, Israel, Netherlands, New Zealand, Poland, Spain, Switzerland
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03499236. Randomized; quadruple masking; primary purpose treatment. Start 2018-09-19 (actual); primary completion 2023-10-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Reducing Lung CongestIon Symptoms in Advanced Heart Failure
- Acronym
- RELIEVE-HF
- Condition
- Heart Failure
- Intervention (Device)
- V-Wave Interatrial Shunt
- Intervention (Other)
- Control
- Lead sponsor
- V-Wave Ltd
Record details
- Record id
cardio:ct-nct03499236- Content hash
93ad51219e71cc9951960ede1924eb9394538e1e17e24cc46b2b52688a99abee